Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$18.07 - $29.37 $4.1 Million - $6.67 Million
226,942 New
226,942 $6.25 Million
Q1 2023

May 15, 2023

BUY
$38.16 - $48.86 $11.8 Million - $15.1 Million
309,192 Added 275.57%
421,393 $20.4 Million
Q4 2022

Feb 14, 2023

SELL
$33.53 - $54.79 $22.4 Million - $36.6 Million
-668,336 Reduced 85.63%
112,201 $4.28 Million
Q3 2022

Nov 14, 2022

BUY
$41.85 - $53.85 $22.4 Million - $28.8 Million
535,277 Added 218.25%
780,537 $39.2 Million
Q2 2022

Aug 15, 2022

BUY
$25.6 - $45.23 $941,235 - $1.66 Million
36,767 Added 17.63%
245,260 $9.83 Million
Q1 2022

May 16, 2022

SELL
$33.33 - $44.6 $10.9 Million - $14.6 Million
-327,451 Reduced 61.1%
208,493 $7.78 Million
Q4 2021

Feb 14, 2022

SELL
$35.36 - $41.86 $843,336 - $998,361
-23,850 Reduced 4.26%
535,944 $21.3 Million
Q3 2021

Nov 15, 2021

BUY
$37.01 - $44.74 $8.01 Million - $9.68 Million
216,343 Added 62.99%
559,794 $20.8 Million
Q2 2021

Aug 16, 2021

BUY
$37.95 - $49.37 $3.11 Million - $4.04 Million
81,917 Added 31.32%
343,451 $14.5 Million
Q1 2021

May 17, 2021

BUY
$46.8 - $68.92 $6.6 Million - $9.72 Million
141,063 Added 117.09%
261,534 $12.4 Million
Q4 2020

Feb 16, 2021

SELL
$47.96 - $67.64 $8.26 Million - $11.6 Million
-172,139 Reduced 58.83%
120,471 $7.35 Million
Q3 2020

Nov 16, 2020

BUY
$45.41 - $57.07 $5.04 Million - $6.33 Million
110,900 Added 61.03%
292,610 $13.7 Million
Q2 2020

Aug 14, 2020

SELL
$42.56 - $54.98 $2.28 Million - $2.95 Million
-53,576 Reduced 22.77%
181,710 $9.22 Million
Q1 2020

May 15, 2020

SELL
$32.37 - $59.36 $2.65 Million - $4.86 Million
-81,940 Reduced 25.83%
235,286 $10.5 Million
Q4 2019

Feb 14, 2020

BUY
$32.22 - $50.07 $10.2 Million - $15.9 Million
317,226 New
317,226 $15.2 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.54B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.